Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$1.9 - $4.18 $35,340 - $77,748
-18,600 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$3.54 - $8.3 $55,192 - $129,405
-15,591 Reduced 45.6%
18,600 $75,000
Q4 2021

Feb 10, 2022

SELL
$7.69 - $19.66 $1,607 - $4,108
-209 Reduced 0.61%
34,191 $274,000
Q3 2021

Nov 12, 2021

BUY
$12.22 - $21.28 $420,368 - $732,032
34,400 New
34,400 $664,000
Q2 2021

Aug 13, 2021

SELL
$9.0 - $15.94 $250,200 - $443,132
-27,800 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$5.24 - $10.14 $145,672 - $281,892
27,800 New
27,800 $251,000

Others Institutions Holding PLXP

About PLx Pharma Inc.


  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.